Zolgensma (onasemnogene abeparvovec)

Hand scales with money and drugs
Special Reports

UPDATED: Most expensive drugs in the US in 2025

One-dose gene therapies with multimillion-dollar price tags make up the top 10 most expensive drugs in the U.S.
Collage poster study of businessmen picture chart arrow goes up

Novartis, Sarepta tipped to drive genomic therapy sales boom

May 15, 2025 12:18pm
Zolgensma

Novartis peels back Zolgensma IT data in older SMA patients

Mar 19, 2025 9:00am
SMA spinal muscular atrophy

Roche picks up FDA nod for easier Evrysdi dosing format in SMA

Feb 12, 2025 2:30pm
Novartis

Novartis readies intrathecal Zolgensma for older SMA patients

Jan 2, 2025 12:30pm
BMS

BMS takes over Novartis' gene therapy plant in Illinois

Apr 26, 2023 10:25am